The North American pharmaceutical industry is the largest market and is considered the pioneer in biopharmaceutical R&D across the globe. Growth in the pharmaceutical industry has drastically increased life expectancy and resulted in a better quality of life. The pharmaceutical industry is driven by the contribution of drug manufactures, research organizations, and pharmaceutical contract manufacturers. The contract manufacturers provide timely and cost-effective services, which in turn, enable the market players to focus on their core competencies. A pharmaceutical contract manufacturer offers comprehensive services to clients ranging from drug development to the packaging of the products. Some of the services offered by contract manufacturers to their clients include the synthesis of the bulk active pharmaceutical ingredients (API), the formulation of bulk drug substances into the final drug products such as pills, topical formulations, and types of injectables. 

Major factors contributing to the growth of the North American pharmaceutical contract manufacturing market include the increasing trend of outsourcing healthcare services. In addition, the patent cliff is another significant factor contributing to the market growth. The ongoing patent expiry of many blockbuster drugs coupled with the decreasing profit margins on branded drugs is forcing most healthcare companies to outsource manufacturing to control costs. Additionally, patent cliffs have cut sales revenue of many branded medications and forced drug makers to consider outsourcing manufacturing to enable control production costs. However, stringent government regulations hinder the market growth. Moreover, rising demand for low-cost services and increasing drug discovery are expected to fuel the market growth in the near future.

The North American pharmaceutical contract manufacturing market can be segmented based on product, type, and services. Based on the product, the market is bifurcated into OTC drugs, API, finished dosage forms include solid dose, liquid dose, and injectable dose, and others such as nutritional products and packaging. Based on type, the market is segmented into sterile manufacturing and non-sterile manufacturing. 

Based on the services, the market is sub-divided into manufacturing services, non-clinical services, and research and development. Among services, the manufacturing segment is expected to be the highest revenue-generating segment owing to the growing medical device manufacturing. The North American pharmaceutical contract manufacturing market report covers the analysis of two economies including the US and Canada. The US held a major share in the North American pharmaceutical contract manufacturing market due to the increasing healthcare expenditure.

There are a large number of contract manufacturers in the region dealing with innovative technologies enabling drug manufacturers in the application of genomics to develop personalized medicines.  AbbVie, Inc., Ajinomoto Althea, Inc., Baxter International Inc., Cambrex Corp., Catalent Inc., Pfizer CentreOne, Thermo Fisher Scientific Inc., and Zoetis, Inc. are some of the contract manufacturers operating in the region. The market players are adopting various strategies such as mergers and acquisitions, geographical expansion, and partnerships to gain significant market share. For instance, in May 2019, Catalent, Inc. acquired Paragon Bioservices, Inc., a contract research and manufacturing organization, for $1.2 billion. Catalent has significantly improved its biologics business by acquiring Paragon’s development and manufacturing capabilities. 

Research Methodology

The market study of the North American Pharmaceutical Contract Manufacturing market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Pharmaceutical Contract Manufacturing Market Research and Analysis by Product
2. North American Pharmaceutical Contract Manufacturing Market Research and Analysis by Type
3. North American Pharmaceutical Contract Manufacturing Market Research and Analysis by Services

The Report Covers

• Comprehensive research methodology of the North American Pharmaceutical Contract Manufacturing market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American Pharmaceutical Contract Manufacturing market.
• Insights about market determinants that are stimulating the North American Pharmaceutical Contract Manufacturing market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players